Association of Serum Leptin Levels with Central Arterial Stiffness in Coronary Artery Disease Patients

Overview

Journal BMC Cardiovasc Disord

Publisher Biomed Central

Specialty Cardiology & Vascular Diseases

Date 2016 May 7

PMID 27151106

Citations 35

Authors

Jen-Pi Tsai

Ji-Hung Wang

Mei-Ling Chen

Chiu-Fen Yang

Yu-Chih Chen

Bang-Gee Hsu

Affiliations

Soon will be listed here.

Abstract

Background: Serum adipokines have roles in the development of arterial stiffness. Our aim was to investigate the relationship of leptin and the surrogate marker carotid-femoral pulse wave velocity (cfPWV) in coronary artery disease (CAD) patients.

Methods: Fasting blood samples were obtained from 105 CAD patients. cfPWV was measured with the SphygmoCor system. A cfPWV > 10 m/s was defined as high arterial stiffness, and ≤ 10 m/s as low arterial stiffness.

Results: Thirty-seven patients (35.2 %) had high arterial stiffness, and had a higher percentage of diabetes (P = 0.001), hypertension (P = 0.010), older age (P = 0.001), and higher systolic blood pressure (SBP) (P < 0.001), diastolic blood pressure (DBP) (P = 0.021), pulse pressure (P = 0.014), and serum leptin level (P = 0.002) compared to patients with low arterial stiffness. Serum leptin levels correlated with the number of angiographically documented stenotic coronary artery vessels (P < 0.001). After adjusting for factors significantly associated with arterial stiffness, multivariate logistic regression analysis showed that leptin (odds ratio = 1.026, 95 % confidence interval: 1.002-1.051, P = 0.037) was a significant independent predictor of arterial stiffness.

Conclusions: Increasing serum concentration of leptin correlated positively with the total number of stenotic coronary arteries, and serum leptin level may predict the development of arterial stiffness in CAD patients.

Citing Articles

Adipokines and Cardiometabolic Heart Failure with Preserved Ejection Fraction: A State-of-the-Art Review.

Theodorakis N, Kreouzi M, Hitas C, Anagnostou D, Nikolaou M Diagnostics (Basel). 2024; 14(23).

PMID: 39682585 PMC: 11640255. DOI: 10.3390/diagnostics14232677.

Exploring the link between leptin levels and metabolic syndrome in elderly Indian patients: Implications for family medicine and primary care practices.

Singhal A, Singh G, Singh S, Karunanand B, Gunjan G, Agrawal S J Family Med Prim Care. 2024; 13(9):3633-3638.

PMID: 39464951 PMC: 11504790. DOI: 10.4103/jfmpc.jfmpc_2008_23.

The Role of Carotid-Femoral Pulse Wave Velocity in a Metabolic Syndrome Patient with Sudden Cardiac Arrest: A Case Report.

Choy H, Bogdanski P, Skrypnik D Healthcare (Basel). 2024; 12(4).

PMID: 38391866 PMC: 10888203. DOI: 10.3390/healthcare12040491.

Associations of Three-Dimensional Anthropometric Body Surface Scanning Measurements and Coronary Artery Disease.

Yang N, Kuo L, Lee C, Ting M, Wu I, Chen S Medicina (Kaunas). 2023; 59(3).

PMID: 36984571 PMC: 10056801. DOI: 10.3390/medicina59030570.

Clinical Study of Metabolic Parameters, Leptin and the SGLT2 Inhibitor Empagliflozin among Patients with Obesity and Type 2 Diabetes.

Szekeres Z, Sandor B, Bognar Z, Ramadan F, Palfi A, Bodis B Int J Mol Sci. 2023; 24(5).

PMID: 36901837 PMC: 10002958. DOI: 10.3390/ijms24054405.

References

Bouloumie A, Marumo T, Lafontan M, Busse R . Leptin induces oxidative stress in human endothelial cells. FASEB J. 1999; 13(10):1231-8. View

Laurent S, Boutouyrie P, Lacolley P . Structural and genetic bases of arterial stiffness. Hypertension. 2005; 45(6):1050-5. DOI: 10.1161/01.HYP.0000164580.39991.3d. View

Mahmud A, Feely J . Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension. 2005; 46(5):1118-22. DOI: 10.1161/01.HYP.0000185463.27209.b0. View

Dhakam Z, Mceniery C, Yasmin , Cockcroft J, Brown M, Wilkinson I . Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens. 2006; 19(2):214-9. DOI: 10.1016/j.amjhyper.2005.08.007. View

Beltowski J . Leptin and atherosclerosis. Atherosclerosis. 2006; 189(1):47-60. DOI: 10.1016/j.atherosclerosis.2006.03.003. View

Wannamethee S, Tchernova J, Whincup P, Lowe G, Kelly A, Rumley A . Plasma leptin: associations with metabolic, inflammatory and haemostatic risk factors for cardiovascular disease. Atherosclerosis. 2006; 191(2):418-26. DOI: 10.1016/j.atherosclerosis.2006.04.012. View

Ryan K, McCance D, Powell L, McMahon R, Trimble E . Fenofibrate and pioglitazone improve endothelial function and reduce arterial stiffness in obese glucose tolerant men. Atherosclerosis. 2006; 194(2):e123-30. DOI: 10.1016/j.atherosclerosis.2006.11.007. View

Laurent S, Boutouyrie P . Arterial stiffness: a new surrogate end point for cardiovascular disease?. J Nephrol. 2007; 20 Suppl 12:S45-50. View

Kim S, Kim H, Ahn C, Park S, Cho Y, Lim S . Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients. Endocr J. 2008; 55(6):1085-92. DOI: 10.1507/endocrj.k08e-182. View

10.

Protogerou A, Blacher J, Stergiou G, Achimastos A, Safar M . Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study. J Am Coll Cardiol. 2009; 53(5):445-51. DOI: 10.1016/j.jacc.2008.09.046. View

11.

da Silva A, do Carmo J, Dubinion J, Hall J . The role of the sympathetic nervous system in obesity-related hypertension. Curr Hypertens Rep. 2009; 11(3):206-11. PMC: 2814329. DOI: 10.1007/s11906-009-0036-3. View

12.

Cecelja M, Chowienczyk P . Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension. 2009; 54(6):1328-36. DOI: 10.1161/HYPERTENSIONAHA.109.137653. View

13.

Vlachopoulos C, Aznaouridis K, Stefanadis C . Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 55(13):1318-27. DOI: 10.1016/j.jacc.2009.10.061. View

14.

Windham B, Griswold M, Farasat S, Ling S, Carlson O, Egan J . Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness. Am J Hypertens. 2010; 23(5):501-7. PMC: 4557869. DOI: 10.1038/ajh.2010.8. View

15.

Rizos E, Agouridis A, Elisaf M . The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review. Curr Vasc Pharmacol. 2010; 8(5):638-44. DOI: 10.2174/157016110792006950. View

16.

Scuteri A, Orru M, Morrell C, Piras M, Taub D, Schlessinger D . Independent and additive effects of cytokine patterns and the metabolic syndrome on arterial aging in the SardiNIA Study. Atherosclerosis. 2011; 215(2):459-64. PMC: 3991114. DOI: 10.1016/j.atherosclerosis.2010.12.023. View

17.

Dhillon S, Belsham D . Leptin differentially regulates NPY secretion in hypothalamic cell lines through distinct intracellular signal transduction pathways. Regul Pept. 2011; 167(2-3):192-200. DOI: 10.1016/j.regpep.2011.01.005. View

18.

Hasan-Ali H, Abd El-Mottaleb N, Hamed H, Abd-Elsayed A . Serum adiponectin and leptin as predictors of the presence and degree of coronary atherosclerosis. Coron Artery Dis. 2011; 22(4):264-9. DOI: 10.1097/MCA.0b013e3283452431. View

19.

Tsai J, Tsai C, Liu H, Lee C, Liou H, Hsu B . Hyperleptinaemia positively correlated with metabolic syndrome in hemodialysis patients. Eur J Intern Med. 2011; 22(6):e105-9. DOI: 10.1016/j.ejim.2011.02.015. View

20.

Vlachopoulos C, Aznaouridis K, Terentes-Printzios D, Ioakeimidis N, Stefanadis C . Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis. Hypertension. 2012; 60(2):556-62. DOI: 10.1161/HYPERTENSIONAHA.112.194779. View